Human IL-6 R alpha Quantikine ELISA Kit
| Name | Human IL-6 R alpha Quantikine ELISA Kit |
|---|---|
| Supplier | R&D Systems |
| Catalog | DR600 |
| Category | ELISA Kit |
| Prices | $509.00, $2,440.00, $16,540.00 |
| Sizes | 1 kit, 1 pack (6 Plates), 1 pack (50 Plates) |
| Assay Type | Solid Phase Sandwich ELISA |
| Sample Type | Cell Culture Supernates (100 uL), Serum (10 uL), EDTA Plasma (10 uL), Heparin Plasma (10 uL), Citrate Plasma (10 uL), Urine (50 uL) |
| Sensitivity | 15.1 pg/mL |
| Range | 31.2 - 2,000 pg/mL (Cell Culture Supernates, Serum, EDTA Plasma, Heparin Plasma, Citrate Plasma, Urine) |
| Format | 96-well strip plate |
| Applications | ELISA |
| Species Reactivities | Human |
| Description | The Quantikine Human IL-6 sR Immunoassay is a 4.5 hour solid phase ELISA designed to measure human IL-6 sR in cell culture supernates, serum, plasma, and urine |
| Gene | IL6R |
| Supplier Page | Shop |
Product images
Product References
Adipogenic Differentiation of Mesenchymal Stem Cells Alters Their - Adipogenic Differentiation of Mesenchymal Stem Cells Alters Their
Munir H, Ward LSC, Sheriff L, Kemble S, Nayar S, Barone F, Nash GB, McGettrick HM. Stem Cells. 2017 Jun;35(6):1636-1646.
Inflammatory Markers and the Risk of Hip and Vertebral Fractures in Men: the - Inflammatory Markers and the Risk of Hip and Vertebral Fractures in Men: the
Cauley JA, Barbour KE, Harrison SL, Cloonan YK, Danielson ME, Ensrud KE, Fink HA, Orwoll ES, Boudreau R. J Bone Miner Res. 2016 Dec;31(12):2129-2138.
IL-6 trans-signaling is another pathway to upregulate Osteopontin. - IL-6 trans-signaling is another pathway to upregulate Osteopontin.
Uchibori T, Matsuda K, Shimodaira T, Sugano M, Uehara T, Honda T. Cytokine. 2017 Feb;90:88-95.
A Novel IL6 Antibody Sensitizes Multiple Tumor Types to Chemotherapy Including - A Novel IL6 Antibody Sensitizes Multiple Tumor Types to Chemotherapy Including
Zhong H, Davis A, Ouzounova M, Carrasco RA, Chen C, Breen S, Chang YS, Huang J, Liu Z, Yao Y, Hurt E, Moisan J, Fung M, Tice DA, Clouthier SG, Xiao Z, Wicha MS, Korkaya H, Hollingsworth RE. Cancer Res. 2016 Jan 15;76(2):480-90.
Prevalent peripheral arterial disease and inflammatory burden. - Prevalent peripheral arterial disease and inflammatory burden.
Cauley JA, Kassem AM, Lane NE, Thorson S. BMC Geriatr. 2016 Dec 9;16(1):213.
Stromal cells positively and negatively modulate the growth of cancer cells: - Stromal cells positively and negatively modulate the growth of cancer cells:
Kawada M, Inoue H, Ohba S, Yoshida J, Masuda T, Yamasaki M, Usami I, Sakamoto S, Abe H, Watanabe T, Yamori T, Shibasaki M, Nomoto A. PLoS One. 2015 Mar 18;10(3):e0119415.
Blood stem cell fate regulation by Delta-1-mediated rewiring of IL-6 paracrine - Blood stem cell fate regulation by Delta-1-mediated rewiring of IL-6 paracrine
Csaszar E, Wang W, Usenko T, Qiao W, Delaney C, Bernstein ID, Zandstra PW. Blood. 2014 Jan 30;123(5):650-8.
An autoinflammatory neurological disease due to interleukin 6 hypersecretion. - An autoinflammatory neurological disease due to interleukin 6 hypersecretion.
Salsano E, Rizzo A, Bedini G, Bernard L, Dall'olio V, Volorio S, Lazzaroni M, Ceccherini I, Lazarevic D, Cittaro D, Stupka E, Paterra R, Farina L, Savoiardo M, Pareyson D, Sciacca FL. J Neuroinflammation. 2013 Feb 21;10:29.
Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor - Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor
Tai YT, Chang BY, Kong SY, Fulciniti M, Yang G, Calle Y, Hu Y, Lin J, Zhao JJ, Cagnetta A, Cea M, Sellitto MA, Zhong MY, Wang Q, Acharya C, Carrasco DR, Buggy JJ, Elias L, Treon SP, Matsui W, Richardson P, Munshi NC, Anderson KC. Blood. 2012 Aug 30;120(9):1877-87.
Inflammatory markers and the risk of hip fracture: the Women's Health Initiative. - Inflammatory markers and the risk of hip fracture: the Women's Health Initiative.
Barbour KE, Boudreau R, Danielson ME, Youk AO, Wactawski-Wende J, Greep NC, LaCroix AZ, Jackson RD, Wallace RB, Bauer DC, Allison MA, Cauley JA. J Bone Miner Res. 2012 May;27(5):1167-76.